Streetbeat News

Stock Prices

GTHX

Shares of G1 Therapeutics have been halted on a circuit breaker due to a sharp decline, with the stock currently down by 29.2%.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:19 pm

CMCSA

DIS

PARA

SNAP

Major U.S. companies Walt Disney and Comcast have increased their advertising spending on Instagram, while Paramount has tripled its spending on Snapchat, following a pause in advertising on Elon Musk's social media platform X due to antisemitic content concerns. Sensor Tower data indicates Disney and Comcast raised their ad spending by 40% and 6% respectively. The shift in ad spending highlights the challenges Musk faces with advertisers leaving X, which has also experienced a 16% drop in monthly active users since Musk's acquisition.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:16 pm

ETSY

Etsy shares are trading lower following the announcement of a restructuring plan that involves an 11% reduction in the Etsy marketplace workforce.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:15 pm

NEE

NextEra Energy Inc. (NYSE:NEE) shares saw a slight increase of 0.02% in the current session, trading at $59.53. Despite a 5.51% rise over the past month, the stock has fallen 29.91% in the past year. The P/E ratio of NextEra Energy is lower than the Electric Utilities industry average, suggesting potential undervaluation or weaker growth prospects. Investors are advised to consider the P/E ratio among other financial metrics and industry trends for a comprehensive analysis.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 6:15 pm

ZWS

KeyBanc analyst Jeffrey D. Hammond downgraded Zurn Elkay Water Solutions Corporation (NYSE:ZWS) to Sector Weight from Overweight due to a weaker non-residential backdrop and emerging incremental cracks in demand. While institutional end markets remain relatively stable, commercial sales are weaker, and the analyst believes that shares are priced for optimistic outcomes. The secular momentum in drinking water may provide some offset, but upward earnings momentum is expected to be challenging. The analyst sees ZWS's long-term outgrowth as less dependent on Hygienics, which may now act more cyclically. The risk/reward for ZWS is now viewed as more balanced, and further re-rating and upward revisions may be difficult amidst weaker demand.

Portfolio Pulse from Nabaparna Bhattacharya

December 13, 2023 | 6:14 pm

CRSP

There has been notable options activity for CRISPR Therapeutics, with sweeps near the ask price for January 19 $65 call options. A total of 252 contracts were traded at $1.75 when the open interest was 7372, with the stock reference price at $58.46. Another sweep of 181 contracts at the same price and open interest occurred simultaneously.

Portfolio Pulse from Charles Gross

December 13, 2023 | 6:10 pm

CE

Celanese Corporation (NYSE:CE) has received 5 analyst ratings in the last quarter, with 2 somewhat bullish and 3 indifferent, and no bullish or bearish ratings. The average price target among these analysts is $141.0, which is slightly below the current price of $141.35, indicating a marginal downside. Over the past month, the average price target has seen a slight increase of 1.81%. Analyst ratings are based on information from company events, financial statements, and insider conversations, and are subject to the analysts' interpretation.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 6:00 pm

SNPS

Analysts have provided positive ratings for Synopsys (NASDAQ:SNPS) with 5 bullish and 6 somewhat bullish ratings in the last quarter. The average price target is $601.45, representing an upside from the current price of $566.34. This target has increased by 9.11% from the previous target of $551.25. Analysts typically review stocks each quarter, and their ratings are based on company performance, financial statements, and insider communications.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 6:00 pm

AXP

HUM

LLY

On CNBC's Halftime Report, experts shared their final trades, which included American Express (AXP), Humana (HUM), and Eli Lilly and Co (LLY). These stock recommendations provide insight into the current market sentiment and potential investment opportunities.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 6:00 pm

LEN

Lennar Corporation (NYSE:LEN) is scheduled to release its quarterly earnings report on December 14, 2023. Analysts predict an EPS of $4.60. Investors are looking for an earnings beat and positive guidance for future growth. Lennar's past earnings performance shows a mix of price changes post-earnings release, with the last quarter resulting in a 2.5% drop despite an EPS beat. Lennar's stock has risen 48.7% over the past 52 weeks, with shares trading at $140.53 as of December 12.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 6:00 pm